Претраживање
Приказ резултата 1-10 од 34
Biological medicines: Three decades of progress / Biološki lekovi: Tri decenije razvoja
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Any medicine whose active substance is present in living organisms, or derived from living organisms, may be considered as a biological product. Vaccines, blood derivatives and products, or hormones isolated from animal ...
Medicines in treatment of addictive disorders / Lekovi u terapiji bolesti zavisnosti
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
It is estimated that annual sales of illegal psychoactive substances account for 8% of total international trade. The large consumption of alcohol and tobacco, as socially accepted drugs, as well as of several classes of ...
Characteristics of pediatric pharmaceutical dosage forms - aspects of individual therapy / Karakteristike farmaceutskih oblika lekova za decu - aspekti individualizacije terapije
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Pediatric oral drug dosage forms can be scientifically challenging to develop, and the choice of which formulation type to develop is often dictated by the physicochemical properties and the taste of the active drug ...
Izveštaj sa predavanja "the editorial world at the lancet medical journal"
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Herbal medicinal products: Requirements on their safe usage / Biljni lekoviti proizvodi: Uslovi za bezbednu primenu
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
As the use of herbal medicinal products is constantly growing, their safety became an important public health issue. In spite of common belief that herbal medicinal products are safe and harmless because they are natural, ...
Development of therapeutic monoclonal antibodies: From the mouse to the human / Razvoj monoklonskih antitela za terapijsku primenu - od mišjih do humanih
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Therapeutical monoclonal antibodies (mAbs) represent one of the fastest growing area of the pharmaceutical industry. High target specificity and specific molecular structure are features that make antibodies attractive ...
Robustness testing of liquid chromatographic method for determination of itraconazole and its impurities applying fractional factorial design / Testiranje robusnosti metode tečne hromatografije za određivanje itrakonazola i njegovih nečistoća primenom frakcionog faktorskog dizajna
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Test of robustness is a part of the method validation and it is carried out in the end of the method development or in the beginning of the method validation. The purpose of robustness testing is to avoid problems in ...
Antineoplastics: Risk assessments / Antineoplastici - procena rizika
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
During the last decades, numerous studies have pointed out that nurses and other hospital workers are exposed to antineoplastic drugs during daily activities due to levels of antineoplastics found in their urine. Although ...
Liquid extemporaneous pharmaceutical preparations for pediatric patients / Tečni farmaceutski preparati za primenu u pedijatriji izrađeni ex tempore
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Many drugs used for the treatment of babies and children are not available in the market in dosage forms appropriate for this population. Moreover, a considerable number of these drugs are not registered for pediatric use. ...
New anticoagulant drugs / Novi antikoagulantni lekovi
(Srpsko lekarsko društvo - Okružna podružnica Kragujevac, Kragujevac, 2012)
Anticoagulants are effective agents for the prevention and treatment of thrombosis and thromboembolic complications, which represent a common cause of morbidity and mortality. Despite their clinical efficiency, traditional ...